2023 Agenda

7:30 Registration and breakfast
8:10 Opening remarks.
Dr. Taymaa May and Dr. Stephanie Lheureux
Session I: Personalized care in patients with newly diagnosed ovarian cancer
Moderator: Dr. Taymaa May
8:15 Effective navigation, investigation, pre-habilitation and support in patients with newly diagnosed advanced ovarian tumors
Paige Gibbings, RN
8:30 Q&A
8:40 Using machine learning algorithm to personalize treatment pathways for patients with newly diagnosed advanced ovarian malignancy.
Dr. Liat Hogen
9:10 Q&A
9:20 “Complex Diva Assessments” and profiling of rare ovarian cancers to guide personalized treatment.
Dr. Stephanie Lheureux
9:35 Update on collaborative initiatives and research opportunities through Ovarian Cancer Canada.
Dr. Alicia Tone, PhD
9:45 Complex Diva Case Presentation and discussion.
Brooke Grant, PA, Dr. Lheureux, Paige Gibbings, RN, Dr. Hogen, Dr. Alicia Tone, PhD
10:10 Health break
Session II: Advances in the management in vulvar cancer
Moderator: Dr. Stephane Laframboise
10:30 Integration of surgical innovation and advances in vulvar cancer surgery.
Dr. Lilian Gien
10:50 Q&A
11:00 Indications for systemic therapy in patients with vulvar cancer.
Dr. Tiffany Zigras
11:20 Q&A
11:30 Advances in radiation therapy in vulvar carcinoma. Dr. Joanne Alfieri
11:50 Q&A
12:00 Lunch with exhibitors
Session III: Molecular characterization and targeted therapies in endometrial cancer
Moderator: Dr. Rachel Kim
1:00 Updated FIGO staging and molecular classification in endometrial cancer.
Dr. Stephen Welch
1:30 Q&A
1:40 Targeted therapies in endometrial cancer.
Dr. Matthew Powell
2:30 Q&A
2:40 Health break
3:00 Management of immunotherapy-related toxicities.
Dr. Neesha Dhani
3:20 Q&A
3:30 Integrating molecular classification and new data into clinical practice- let’s debate.

  • Distillation presentation: Dr. Rachel Kim
  • Panel discussion: Dr. Welch, Dr. Powell, Dr. Dhani, Dr. Kim
4:30 Closing Remarks.
Dr. Taymaa May and Dr. Stephanie Lheureux